Education
About Us
Working with TipRanks
Follow Us
Wellnex Life Ltd (DE:22W0)
FRANKFURT:22W0
22W0 Stock Chart & Stats
€0.04
>-€0.01(-1.97%)
At close: 4:00 PM EST
€0.04
>-€0.01(-1.97%)
Day’s Range― - ―
52-Week Range€0.04 - €0.38
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€4.60M
Enterprise Value€12.65M
Total Cash (Recent Filing)€497.00K
Total Debt (Recent Filing)€5.45M
Price to Earnings (P/E)―
Beta1.92
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding69,955,475
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product Focus & InnovationWellnex’s focus on OTC pain relief and topical/delivery-format innovations provides a durable product differentiation pathway. Specialized formulations and delivery expertise support repeat consumer demand, licensing opportunities and retailer interest, enabling sustained brand-led growth if commercial execution follows.
Pharmacy And Retail DistributionEstablished access to pharmacies, retailers and consumer channels creates a resilient go-to-market footprint. Shelf presence in pharmacy networks supports recurring purchases and trust for health products, improves route-to-market scalability and helps new SKUs gain traction via existing wholesale relationships.
Manageable Leverage And Asset BaseA moderate debt-to-equity ratio and a relatively healthy equity ratio give Wellnex financial flexibility versus highly leveraged peers. This balance sheet profile reduces near-term solvency risk and preserves capacity to fund distribution, product launches or working-capital needs while pursuing margin improvement initiatives.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flow constrains the company’s ability to self-fund marketing, inventory and R&D required to scale OTC brands. Continued cash burn increases reliance on external financing, which can dilute shareholders or raise borrowing costs and limit strategic optionality over the medium term.
Ongoing Profitability ShortfallsSustained negative net profit and EBIT margins indicate the business model has yet to achieve operating leverage. Without durable margin expansion, the company will struggle to generate returns on invested capital, hindering reinvestment and making long-term value creation dependent on material margin or revenue improvements.
Modest Revenue GrowthOnly marginal top-line growth limits the company’s ability to leverage fixed costs and achieve scale economies in manufacturing, marketing and distribution. In a competitive consumer healthcare market, tepid revenue momentum raises the bar for product innovation or channel expansion to sustainably reverse losses.
Wellnex Life Ltd News
22W0 FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest stock price was €0.04 and its highest was €0.38 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is €4.60M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 10 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Aug 29, 2025. The company reported -€0.067 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.067.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 69,955,475 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -€0.067 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in DE:22W0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
DE:22W0 Sentiment 50%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.69%
12-Months-Change
Fundamentals
Return on Equity
-184.71%
Trailing 12-Months
Asset Growth
-18.52%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited develops health and wellness solutions in Australia. The company provides organic baby skincare products under the Little Innoscents; nutritional support products under the Performance Inspired; iron gummies under The Iron Company; organic milk under the Uganic; natural energy products under the Wakey Wakey; smooth textured capsules under the Liquigesic; and garlic products under the SupaGarlic brands. It also offers bin cleanser solutions under the Bin Buddy; medical products under the Bird Healthcare; gel plasters for treating blisters, corns, cracked heels, and cold sores under the Compeed; oral emergency contraception pills under the EllaOne; skincare solutions under the Koéna; canned meats under the Plumrose; snacks under the Simply7; skincare products under the edited; natural herbal skincare products under the naked klay; and natural essential oil blends under the Planet Remedy brands. In addition, the company provides contract manufacturing services. Wellnex Life Limited has a collaboration with Onelife Botanicals for the manufacture, distribution, and sales of cannabis and hemp-based products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Melbourne, Australia.
Technical Analysis
EVE Health Group Limited
―
Nuchev Pty Ltd
―
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---